Abstract:Background: Lower-risk (LR) myelodysplastic syndromes (MDS) are a group of hematologic disorders impacting patient survival and quality of life. Existing published survival data focus on describing duration of survival; however, it is diffi cult to interpret the seriousness of the disease objectively, since survival data have not been compared with data from the general population. Aims: To quantify the real-world life-year loss due to LR-MDS in comparison with the general population in Germany, France, Italy,… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.